You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

400 Results
Drug
Other Name(s): Kimmtrak®
Oct 2025
Guidelines and Advice
Status: Current
ID: GL 19-7
Mar 2024
Drug
Other Name(s): Imjudo®
Apr 2024
Regimen
Cancer Type:
Head and Neck, 
Nasopharynx
Intent: Palliative
Apr 2024
Document
Jun 2024
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Intent: Curative
Funding:
ODB - General Benefit
    filgrastim (biosimilars) - refer to ODB Formulary for details
Nov 2025
Regimen
Cancer Type:
Lung, 
Small Cell
Intent: Palliative
Feb 2025
Drug
Other Name(s): Tecvayli®
Oct 2025
Guidelines and Advice
Status: Current
ID: ES 6-25
Oct 2024
Document
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab and Trastuzumab (Biosimilar) - First-line Treatment of Advanced HER2-Positive Gastric or Esophagogastric Junction Adenocarcinoma
Dec 2024

Pages